Aleks joined Novo Holdings in September 2014 in the Principal Investments team taking part in managing and developing a growing portfolio of private equity investments. He became the Director of the REPAIR Impact Fund investing in early-stage infectious disease programs in February 2018 at which point he also became a Partner with the Novo Seeds team. Aleks joined the Bio-industrial investments team as a Partner in January of 2023 while still also leading the REPAIR Impact Fund.
Prior to joining Novo Holdings, Aleks was employed as Vice President in Baxter International in Illinois and Shanghai, working with global M&A licensing, growth strategies, investment prioritization and go-to-market planning. Other previous employments include Pfizer Global Research and Development, Thomson Scientific & Healthcare and McKinsey & Company (all U.S.A.).
Aleks holds a Ph.D. in Biochemical Engineering (1999) and a M.Sc. in Chemical Engineering Practice (1995) from Massachusetts Institute of Technology.
Passion, accountability, and collaboration. At Paratek, we count on each other to build a company that saves lives. Learn more about life @Paratek.Explore Careers
Working in a collaborative environment to provide a life-saving therapy is not only empowering but inspiring. It is amazing to spend each day working with a team dedicated to our mission in creating positive stories for our patients and their caregivers.